Dark Forest Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$886K Buy
+1,784
New +$791K 0.06% 530
2026
Q1
Sell
-706
Closed -$320K 1167
2025
Q4
$320K Sell
706
-1,304
-65% -$562K 0.01% 873
2025
Q3
$787K Buy
+2,010
New +$840K 0.03% 815
2025
Q1
Sell
-1,657
Closed -$667K 1456
2024
Q4
$667K Buy
1,657
+585
+55% +$271K 0.1% 312
2024
Q3
$499K Buy
+1,072
New +$515K 0.06% 387
2022
Q2
Sell
-19
Closed -$5K 1405
2022
Q1
$5K Buy
19
+17
+850% +$4.04K ﹤0.01% 1112
2021
Q4
$0 Sell
2
-131
-98% -$25.5K ﹤0.01% 1802
2021
Q3
$24K Buy
+133
New +$26K 0.01% 766

Other funds holding VRTX

Dark Forest Capital Management's VRTX Position: Q2 2026 in Review

Dark Forest Capital Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 1,784 shares worth $886K. The stake represents 0.06% of the portfolio and ranks #530 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in VRTX as recently as Q4 2025.

Dark Forest Capital Management first reported a position in VRTX in Q3 2021 and has held it in 8 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Dark Forest Capital Management held 1,784 shares of Vertex Pharmaceuticals worth $886K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Dark Forest Capital Management position in Q2 2026.
  • Vertex Pharmaceuticals made up 0.06% of Dark Forest Capital Management's portfolio in Q2 2026, its #530 holding.
  • Dark Forest Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.